Verve Therapeutics Stock Alpha and Beta Analysis

VERV Stock  USD 5.97  0.18  2.93%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Verve Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Verve Therapeutics over a specified time horizon. Remember, high Verve Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Verve Therapeutics' market risk premium analysis include:
Beta
1.93
Alpha
0.44
Risk
5.71
Sharpe Ratio
0.0558
Expected Return
0.32
Please note that although Verve Therapeutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Verve Therapeutics did 0.44  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Verve Therapeutics stock's relative risk over its benchmark. Verve Therapeutics has a beta of 1.93  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Verve Therapeutics will likely underperform. At this time, Verve Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Fair Value is likely to climb to 1.01 in 2025, whereas Book Value Per Share is likely to drop 4.14 in 2025.

Enterprise Value

353.84 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Verve Therapeutics Backtesting, Verve Therapeutics Valuation, Verve Therapeutics Correlation, Verve Therapeutics Hype Analysis, Verve Therapeutics Volatility, Verve Therapeutics History and analyze Verve Therapeutics Performance.
For more information on how to buy Verve Stock please use our How to Invest in Verve Therapeutics guide.

Verve Therapeutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Verve Therapeutics market risk premium is the additional return an investor will receive from holding Verve Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Verve Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Verve Therapeutics' performance over market.
α0.44   β1.93

Verve Therapeutics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Verve Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Verve Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Verve Therapeutics Market Price Analysis

Market price analysis indicators help investors to evaluate how Verve Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verve Therapeutics shares will generate the highest return on investment. By understating and applying Verve Therapeutics stock market price indicators, traders can identify Verve Therapeutics position entry and exit signals to maximize returns.

Verve Therapeutics Return and Market Media

The median price of Verve Therapeutics for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 6.42 with a coefficient of variation of 14.53. The daily time series for the period is distributed with a sample standard deviation of 0.97, arithmetic mean of 6.69, and mean deviation of 0.84. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635
01/03/2025
2
Acquisition by Ashe Andrew D. of 36000 shares of Verve Therapeutics subject to Rule 16b-3
01/17/2025
3
Verve Therapeutics Stock Price Up 5.6 percent - Whats Next - MarketBeat
01/30/2025
4
Verve Therapeutics Trading Up 6.7 percent Heres What Happened
02/05/2025
5
Verve Therapeutics Shares Gap Up Should You Buy
02/06/2025
6
Acquisition by Allison Dorval of 75000 shares of Verve Therapeutics at 6.01 subject to Rule 16b-3
02/07/2025
7
Investors Who Lost Money on Verve Therapeutics, Inc. Should Contact Levi Korsinsky About Pending Class Action - VERV - ACCESS Newswire
02/19/2025
8
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 ...
02/27/2025
9
Verve Therapeutics Full Year 2024 Earnings Beats Expectations
02/28/2025

About Verve Therapeutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Verve or other stocks. Alpha measures the amount that position in Verve Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Payables Turnover0.950.9
Days Of Inventory On Hand4.9E-54.3E-5

Verve Therapeutics Upcoming Company Events

As portrayed in its financial statements, the presentation of Verve Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Verve Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Verve Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Verve Therapeutics. Please utilize our Beneish M Score to check the likelihood of Verve Therapeutics' management manipulating its earnings.
7th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Verve Therapeutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Verve Stock Analysis

When running Verve Therapeutics' price analysis, check to measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.